| |
|
Form Serial Number: |
DA20240328E00342
|
| 1.
Date of relevant event: |
09/03/2024
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
01548 |
| 4.
Name of listed corporation: |
Genscript Biotech Corporation |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
2,123,264,624 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
Wang |
| (Other names) |
Ye |
|
|
|
| 10.
Name of director (Chinese): |
王烨 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 12041 | The number of shares in which you are interested has reduced because:
expiry or cancellation without exercise of equity derivatives under which (choose one):
you had a right to take the underlying shares |
|
|
|
30,000 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 839,743,753 | 39.55 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 839,713,753 | 39.55 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
| 2401 | A concert party to an agreement to buy shares described in s.317(1)(a) |
| |
| 2307 | Founder of a discretionary trust who can influence how the trustee exercises his discretion |
| |
| |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| Long position | | 4105 | Unlisted derivatives - Physically settled |
| 31/12/2014 | 31/07/2025 | USD | 1 | USD | 0.062 | | | 38,150,000 |
| Long position | | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| | | | | | | | | 150,000 |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| Spouse | Hu Zhiyong | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Genscript Corporation | Suite 606, 1220 N. Market Street, Wilmington, DE 19801, County of New Castle, USA | Zhang Fangliang | 5.12 | Y | |
| Genscript Corporation | Suite 606, 1220 N. Market Street, Wilmington, DE 19801, County of New Castle, USA | Wang Luquan | 22.76 | Y | |
| Genscript Corporation | Suite 606, 1220 N. Market Street, Wilmington, DE 19801, County of New Castle, USA | Wang Ye | 3.79 | Y | |
| Genscript Corporation | Suite 606, 1220 N. Market Street, Wilmington, DE 19801, County of New Castle, USA | Zhang Fangliang | 21.34 | Y | |
| Genscript Corporation | Suite 606, 1220 N. Market Street, Wilmington, DE 19801, County of New Castle, USA | Wang Ye | 8.42 | Y | |
| Genscript Corporation | Suite 606, 1220 N. Market Street, Wilmington, DE 19801, County of New Castle, USA | Zhang Fangliang | 4.60 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| 2017 YE WANG FAMILY TRUST | Addresses of individuals are not displayed. | | 5103 | Founder of a discretionary trust who can influence how the trustee exercises his discretion |
| |
| Ren-Shiu Foundation Inc. | Addresses of individuals are not displayed. | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| Zhang Fangliang | Addresses of individuals are not displayed. | 0 |
| Wang Luquan | Addresses of individuals are not displayed. | 638,000 |
| Total number of shares in which a director is interested under sections 317 and 318 | 839,713,753 |
|
| |
| 34.
Supplementary information: |
Ms. Wang Ye was granted restricted shares underlying 300,000 shares of the Company on 31 May 2021 that will vest in five annual installments on 31 May 2022 to 31 May 2026. 30,000 unvested restricted shares lapsed on 9 March 2024.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
1
|
|
Date of filing this Form 3A: |
28/03/2024
(dd/mm/yyyy)
|
| |